我們已在上線! 進一步了解
SXTPW圖示

60 Degrees Pharmaceuticals Warrant

0.0225 USD
-0.0025
10%
收盤時 已更新 10月16日 下午4:00 EDT
1天
-10%
5天
-10%
1個月
-35.16%
3個月
-22.41%
6個月
-72.89%
今年迄今
-65.33%
1年
-48.51%
5年
-97.22%
10年
-97.22%
 

關於: 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

員工: 3

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於SXTPW的最新新聞文章。

價格圖表採用Lightweight Charts™實作